01mrt

Impact of Machine-Learning CT-derived Fractional Flow Reserve for the Diagnosis and Management of Coronary Artery Disease in the Randomized CRESCENT Trials.

Auteurs: Nous FMA, Budde RPJ, Lubbers MM, Yamasaki Y, Kardys I, Bruning TA, Akkerhuis JM, Kofflard MJM, Kietselaer B, Galema TW, Nieman K.
01jan

Exercise and myocardial injury in hypertrophic cardiomyopathy.

Auteurs: Cramer, Gommans, Dieker, Michels, Verheugt, de Boer, Bakker, Fouraux, Timmermans, Kofflard, Brouwer
01jan

Clinical outcomes at 2 years of the Absorb bioresorbable vascular scaffold versus the Xience drug-eluting metallic stent in patients presenting with acute coronary syndrome versus stable coronary disease-AIDA trial substudy.

Auteurs: Tijssen RYG, van der Schaaf RJ, Kraak RP, Vink MA, Hofma SH, Arkenbout EK, Weevers APJD, Kerkmeijer LSM, Onuma Y, Serruys PW, Beijk MAM, Koch KT, Baan J Jr, Vis MM, Piek JJ, Tijssen JGP, Henriques JPS, de Winter RJ, Wykrzykowska JJ.
01jan

A paradox in sex-specific clinical outcomes after bioresorbable scaffold implantation: 2-year results from the AIDA trial.

Auteurs: Kerkmeijer LSM, Tijssen RYG, Hofma SH, Pinxterhuis TH, Kraak RP, Kalkman DN, van der Schaaf RJ, Arkenbout EK, Weevers APJD, Beijk MA, Baan J Jr, Vis MM, Koch KT, Tijssen JGP, Piek JJ, Henriques JPS, de Winter RJ, Wykrzykowska JJ.
01jan

A randomised comparison of the effect of haemodynamic monitoring with CardioMEMS in addition to standard care on quality of life and hospitalisations in patients with chronic heart failure : Design and rationale of the MONITOR HF multicentre randomised clinical trial.

Auteurs: Brugts JJ, Veenis JF, Radhoe SP, Linssen GCM, van Gent M, Borleffs CJW, van Ramshorst J, van Pol P, Tukkie R, Spee RF, Emans ME, Kok W, van Halm V, Handoko L, Beeres SLMA, Post MC, Boersma E, Lenzen MJ, Manintveld OC, Koffijberg H, van Baal P, Versteegh M, Smilde TD, van Heerebeek L, Rienstra M, Mosterd A, Delnoy PPH, Asselbergs FW, Brunner-La Rocca HP, de Boer RA.